11:05 11:20: Mary Conrad, Cubist* – Vivo” Resistance Frequency Assay May Predict the Clinical “An “In Resistance Liability of Antibacterial Agents” 11:20 11:40: Ramnik Xavier, MGH – Dynamics of the Human Infant Gut Microbiome in “The Development and in Progression toward autoimmunity.” 11:40 11:55 Shuangchun Yan, MGH* – identification of patients at elevated risk of developing “Rapid severe infections” 12:00 1:30: Lunch / Poster Session – 12:00 4:10: Novel Approaches to Therapeutics – Session III: Moderator: Conery, MGH 1:30 1:50: Mike Pucci, Spero – "Attacking virulence: a New Approach for the Treatment of Bacterial Infections" 1:50 2:05: Brian Conlon, Northeastern* – of ADEP 4 antibiotic combinations for activity against “Evaluation MRSA.” 2:05 2:25: Amy Spoering, Novobiotic – "A Non-traditional Approach to Cultivation of Microbes for Antibiotic Drug Discovery " 2:25 2:45: Tim Lu, MIT – "Sequence-Specific Antimicrobials for Microbiome Engineering and Antibiotic-Resistant Pathogens" 2:45 3:15: Break –
11:05 – 11:20: Mary Conrad, Cubist* “An “In Vivo” Resistance Frequency Assay May Predict the Clinical Resistance Liability of Antibacterial Agents” 11:20 – 11:40: Ramnik Xavier, MGH “The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward autoimmunity.” 11:40 – 11:55 Shuangchun Yan, MGH* “Rapid identification of patients at elevated risk of developing severe infections” 12:00 – 1:30: Lunch / Poster Session 12:00 – 4:10: Novel Approaches to Therapeutics Session III: Moderator: Conery, MGH 1:30 – 1:50: Mike Pucci, Spero "Attacking virulence: a New Approach for the Treatment of Bacterial Infections" 1:50 – 2:05: Brian Conlon, Northeastern* “Evaluation of ADEP 4 antibiotic combinations for activity against MRSA.” 2:05 – 2:25: Amy Spoering, Novobiotic "A Non-traditional Approach to Cultivation of Microbes for Antibiotic Drug Discovery " 2:25 – 2:45: Tim Lu, MIT "Sequence-Specific Antimicrobials for Microbiome Engineering and Antibiotic-Resistant Pathogens" 2:45 – 3:15: Break
2015-BAARN-Agenda-FINAL.docx